China Rehabilitation Research Center is a Chinese medical research center in Beijing. The Pacific Business News said the CRRC "is considered one of China's pre-eminent rehabilitation hospitals". It has 700 hospital beds and cares for roughly 300,000 patients every year.

During the past decade, China Rehabilitation Research Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "China Rehabilitation Research Center" #1 collaborator was "China Rehabilitation Research Center" with 2 trials as a collaborator, "Ankang City Central Hospital" with 1 trials as a collaborator, "Beihua University" with 1 trials as a collaborator, "Beijing Chuiyangliu Hospital(Beijing Minimally Invasive Hospital)" with 1 trials as a collaborator and "Beijing Shijitan Hospital,the 9th Clinical Medical College of Peking university" with 1 trials as a collaborator. Other collaborators include 53 different institutions and companies that were collaborators in the rest 63 trials.

According to Clinical.Site data, the most researched conditions in "China Rehabilitation Research Center" are "Stroke" (4 trials), "Spinal Cord Injuries" (2 trials), "Adverse Drug Reaction" (1 trials), "Cinepazide" (1 trials) and "Cognitive Impairment" (1 trials). Many other conditions were trialed in "China Rehabilitation Research Center" in a lesser frequency.

Most popular intervention types in "China Rehabilitation Research Center" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (1 trials), "Aspirin / Clopidogrel, Atorvastatin / Simvastatin" (1 trials), "Asprin / Clopidogrel, Atorvastatin / Simvastatin" (1 trials), "Butylphthalide Soft Capsules" (1 trials) and "Lithium Carbonate" (1 trials). Other intervention names were less common.

The vast majority of trials in "China Rehabilitation Research Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "China Rehabilitation Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in China Rehabilitation Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in China Rehabilitation Research Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".